FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to experimental pharmacology and ophthalmology, and is intended for the correction of microcirculatory disorders in ischemic conditions of the retina. The method for correction of microcirculatory disorders of the retina in the experiment includes the introduction of asialated erythropoietin to a laboratory animal in an amount of 2.4 mcg/kg once on the 1st day of the experiment intraperitoneally 30 minutes before modeling the pathology.
EFFECT: use of the invention improves the efficiency of correction of microcirculatory disorders in modeling retinal ischemia.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF MICROCIRCULATORY DISORDERS OF THE RETINA WITH LOW-SIALATED ERYTHROPOIETIN | 2021 |
|
RU2750966C1 |
| METHOD FOR PREVENTION OF ISCHEMIA OF RETINA WITH ERYTHROPOETIN EXPERIMENTALLY | 2013 |
|
RU2539629C1 |
| METHOD FOR PREVENTING MICROCIRCULATION DISORDERS IN KIDNEYS WITH ASIALISED ERYTHROPOIETIN IN EXPERIMENT | 2018 |
|
RU2696864C1 |
| METHOD FOR RETINAL ISCHEMIA-REPERFUSION PREVENTION BY MINOXIDIL IN EXPERIMENT | 2016 |
|
RU2643671C1 |
| METHOD FOR PREVENTION OF ISCHEMIA OF RETINA EXPERIMENTALLY | 2013 |
|
RU2539630C1 |
| METHOD FOR PREVENTING ISCHEMIC NEUROPATHY OF THE OPTIC NERVE BY CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2017 |
|
RU2643579C1 |
| METHOD OF PLACENTAL MICROCIRCULATION CORRECTION BY ASIALIZED ERYTHROPOIETIN IN ADMA-LIKE MODEL OF PREECLAMPSIA | 2019 |
|
RU2709833C1 |
| METHOD OF PLACENTAL MICROCIRCULATION CORRECTION BY PEPTIDE IMITATING B ERYTHROPOIETIN ALPHA-SPIRAL WITH ADMA-LIKE PRE-ECLAMPSIA MODEL | 2020 |
|
RU2731919C1 |
| METHOD FOR CORRECTING MICROCIRCULATION DISORDERS IN KIDNEY WITH PEPTIDE THAT MIMICS ALPHA-HELIX B OF ERYTHROPOIETIN IN ISCHEMIA-REPERFUSION INJURY | 2021 |
|
RU2751413C1 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION WITH ASIALISED ERYTHROPOIETIN IN AN ADMA-LIKE MODEL OF PREECLAMPSIA | 2019 |
|
RU2707060C1 |
